Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Human Siglec-3/CD33 Antibody, R&D Systems™

Mouse Monoclonal Antibody
$200.50 - $467.50
Specifications
| Antigen | Siglec-3/CD33 |
|---|---|
| Clone | 996816 |
| Dilution | Flow Cytometry 0.25 μg/106 cells, CyTOF-ready |
| Applications | Flow Cytometry, CyTOF |
| Classification | Monoclonal |
| Catalog Number | Mfr. No. | Quantity | Price | Quantity & Availability | |||||
|---|---|---|---|---|---|---|---|---|---|
| Catalog Number | Mfr. No. | Quantity | Price | Quantity & Availability | |||||
MAB11372SP
![]() |
R&D Systems
MAB11372SP |
25 μg |
Each for $200.50
|
|
|||||
MAB11372100
![]() |
R&D Systems
MAB11372100 |
100 μg |
Each for $467.50
|
|
|||||
Description
Siglec-3/CD33 Monoclonal specifically detects Siglec-3/CD33 in Human samples. It is validated for Flow Cytometry, CyTOF-ready.Specifications
| Siglec-3/CD33 | |
| Flow Cytometry 0.25 μg/106 cells, CyTOF-ready | |
| Monoclonal | |
| Mouse | |
| Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied as a 0.2 μm filtered solution in PBS. | |
| CD33, CD33 antigen, CD33 antigen (gp67), CD33 molecule, FLJ00391, gp67, myeloid cell surface antigen CD33, p67, sialic acid binding Ig-like lectin 3, Sialic acid-binding Ig-like lectin 3, Siglec3, SIGLEC-3, SIGLEC3gp67 | |
| Mouse myeloma cell line, NS0-derived human Siglec-3, Asp18-His259, Accession No. P20138 | |
| Primary | |
| Reconstitute at 0.5 mg/mL in sterile PBS. | |
| Detects human Siglec-3 in direct ELISAs. |
| 996816 | |
| Flow Cytometry, CyTOF | |
| Unconjugated | |
| Human | |
| P20138 | |
| 945.0 | |
| IgG1 | |
| Protein A or G purified from hybridoma culture supernatant | |
| Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70 °C as supplied. 1 month, 2 to 8 °C under sterile conditions after reconstitution. 6 months, -20 to -70 °C under sterile conditions after reconstitution. |
Spot an opportunity for improvement?Share a Content Correction
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title